Previous Article | Next Article 
Journal of Virology, September 1999, p. 7627-7632, Vol. 73, No. 9
0022-538X/99/$04.00+0
Epstein-Barr Virus BARF1 Protein Is Dispensable for
B-Cell Transformation and Inhibits Alpha Interferon Secretion from
Mononuclear Cells
Jeffrey I.
Cohen* and
Kristen
Lekstrom
Medical Virology Section, Laboratory of
Clinical Investigation, National Institute of Allergy and
Infectious Diseases, Bethesda, Maryland 20892
Received 24 March 1999/Accepted 14 June 1999
The Epstein-Barr virus (EBV) BARF1 gene encodes a soluble
colony-stimulating factor 1 (CSF-1) receptor that neutralizes the effects of CSF-1 in vitro. To study the effect of BARF1 on EBV-induced transformation, we added recombinant BARF1 to B cells in the presence of EBV. BARF1 did not enhance transformation of B cells by EBV in
vitro. To study the role of BARF1 in the context of EBV infection, we
constructed a recombinant EBV mutant with a large deletion followed by
stop codons in the BARF1 gene as well as a recombinant virus with a
wild-type BARF1 gene. While BARF1 has previously been shown to act as
an oncogene in several cell lines, the EBV BARF1 deletion mutant
transformed B cells and initiated latent infection, and the B cells
transformed with the BARF1 mutant virus induced tumors in SCID mice
with an efficiency similar to that of the wild-type recombinant virus.
Since human CSF-1 stimulates secretion of alpha interferon from
mononuclear cells and BARF1 encodes a soluble CSF-1 receptor, we
examined whether recombinant BARF1 or BARF1 derived from EBV-infected B
cells could inhibit alpha interferon secretion. Recombinant BARF1
inhibited alpha interferon secretion by mononuclear cells in a
dose-dependent fashion. The B cells transformed with mutant BARF1 EBV
showed reduced inhibition of alpha interferon secretion by human
mononuclear cells when compared with the B cells transformed with
wild-type recombinant virus. These experiments indicate that BARF1
expressed from the EBV genome directly inhibits alpha interferon
secretion, which may modulate the innate host response to the virus.
*
Corresponding author. Mailing address: Laboratory of
Clinical Investigation, Bldg. 10, Rm. 11N214, National Institutes of Health, Bethesda, MD 20892. Phone: (301) 496-5221. Fax: (301) 496-7383. E-mail: jcohen{at}niaid.nih.gov.
Journal of Virology, September 1999, p. 7627-7632, Vol. 73, No. 9
0022-538X/99/$04.00+0
This article has been cited by other articles:
-
de Turenne-Tessier, M., Ooka, T.
(2007). Post-translational modifications of Epstein Barr virus BARF1 oncogene-encoded polypeptide. J. Gen. Virol.
88: 2656-2661
[Abstract]
[Full Text]
-
Houali, K., Wang, X., Shimizu, Y., Djennaoui, D., Nicholls, J., Fiorini, S., Bouguermouh, A., Ooka, T.
(2007). A New Diagnostic Marker for Secreted Epstein-Barr Virus Encoded LMP1 and BARF1 Oncoproteins in the Serum and Saliva of Patients with Nasopharyngeal Carcinoma. Clin. Cancer Res.
13: 4993-5000
[Abstract]
[Full Text]
-
Sheng, W., Decaussin, G., Ligout, A., Takada, K., Ooka, T.
(2003). Malignant Transformation of Epstein-Barr Virus-Negative Akata Cells by Introduction of the BARF1 Gene Carried by Epstein-Barr Virus. J. Virol.
77: 3859-3865
[Abstract]
[Full Text]
-
Rivailler, P., Cho, Y.-g., Wang, F.
(2002). Complete Genomic Sequence of an Epstein-Barr Virus-Related Herpesvirus Naturally Infecting a New World Primate: a Defining Point in the Evolution of Oncogenic Lymphocryptoviruses. J. Virol.
76: 12055-12068
[Abstract]
[Full Text]
-
Jabs, W. J., Wagner, H. J., Maurmann, S., Hennig, H., Kreft, B.
(2002). Inhibition of macrophage inflammatory protein-1alpha production by Epstein-Barr virus. Blood
99: 1512-1516
[Abstract]
[Full Text]
-
Tune, C. E., Pilon, M., Saiki, Y., Dosch, H.-M.
(2002). Sustained Expression of the Novel EBV-Induced Zinc Finger Gene, ZNFEB, Is Critical for the Transition of B Lymphocyte Activation to Oncogenic Growth Transformation. J. Immunol.
168: 680-688
[Abstract]
[Full Text]
-
Rivailler, P., Jiang, H., Cho, Y.-g., Quink, C., Wang, F.
(2002). Complete Nucleotide Sequence of the Rhesus Lymphocryptovirus: Genetic Validation for an Epstein-Barr Virus Animal Model. J. Virol.
76: 421-426
[Abstract]
[Full Text]
-
Cho, Y.-G., Ramer, J., Rivailler, P., Quink, C., Garber, R. L., Beier, D. R., Wang, F.
(2001). An Epstein-Barr-related herpesvirus from marmoset lymphomas. Proc. Natl. Acad. Sci. USA
98: 1224-1229
[Abstract]
[Full Text]
-
Decaussin, G., Sbih-Lammali, F., Mireille de Turenne-Tessier, , Bouguermouh, A., Ooka, T.
(2000). Expression of BARF1 Gene Encoded by Epstein-Barr Virus in Nasopharyngeal Carcinoma Biopsies. Cancer Res.
60: 5584-5588
[Abstract]
[Full Text]
-
Cohen, J. I.
(2000). Epstein-Barr Virus Infection. NEJM
343: 481-492
[Full Text]
-
Chung, K. M., Lee, J., Kim, J.-E., Song, O.-K., Cho, S., Lim, J., Seedorf, M., Hahm, B., Jang, S. K.
(2000). Nonstructural Protein 5A of Hepatitis C Virus Inhibits the Function of Karyopherin beta 3. J. Virol.
74: 5233-5241
[Abstract]
[Full Text]
-
Hausen, A. z., Brink, A. A. T. P., Craanen, M. E., Middeldorp, J. M., Meijer, C. J. L. M., van den Brule, A. J. C.
(2000). Unique Transcription Pattern of Epstein-Barr Virus (EBV) in EBV-carrying Gastric Adenocarcinomas: Expression of the Transforming BARF1 Gene. Cancer Res.
60: 2745-2748
[Abstract]
[Full Text]
-
Savard, M., Bélanger, C., Tardif, M., Gourde, P., Flamand, L., Gosselin, J.
(2000). Infection of Primary Human Monocytes by Epstein-Barr Virus. J. Virol.
74: 2612-2619
[Abstract]
[Full Text]